The covid-19 pandemic has forced the scientific world to make a huge number of decisions in an unimaginably […]
The study failed to meet statistical significance for the primary endpoint, however, it did show a number of […]
The move follows a portfolio review by the French drug giant
The new condition is called Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS)
It is not certain how much more clinical benefit Sarclisa has over existing therapies, the Institute said
The research also suggests that coronavirus was more infectious than previously estimated
Updated Date: Mon, 01 Jun 2020 00:00:00 EDT
Updated Date: Mon, 01 Jun 2020 00:00:00 EDT
Updated Date: Mon, 01 Jun 2020 00:00:00 EDT
Updated Date: Mon, 01 Jun 2020 00:00:00 EDT